IGF2 and Nephroblastoma: Several earlier investigations in Wilms tumor, colorectal cancer, malignant pheochromocytoma, and hepatocellular carcinoma tissues demonstrated positive relationships between miR-483 expression and IGF-II mRNA levels, supporting this theory (Ma et al., 2011).